At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Center Randomized Controlled Phase II Trial of Exercise to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN)
In Brief
A clinical study evaluating Best Practice, Exercise Counseling, and 4 other interventions for Chemotherapy-Induced Peripheral Neuropathy and 2 related conditions. Active but no longer recruiting, targeting 133 participants across 93 sites.
Detailed Summary
This phase II trial studies whether using exercise is better than the usual approach for treating chemotherapy-induced peripheral neuropathy (CIPN). CIPN occurs when chemotherapy damages the nerves communicating between the brain, spinal cord, and the rest of the body. The usual approach for treating CIPN is treatment with drugs that help reduce symptoms of other types of neuropathy (for example, from diabetes). However, these drugs do not treat all symptoms of CIPN. Exercise may help to reduce CIPN symptoms.
Study Details
Timeline
Interventions
Receive standard of care
Meet with certified exercise instructor
Participate in the EXCAP program
Undergo MRI
Undergo tactile sensitivity test
Ancillary studies